Remove tag medtronic-minimed
article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Neurostimulation Devices: Minimally invasive procedures targeting specific nerves for pain relief. Technology: Closed-loop neuromodulation - Implantable devices like Medtronic's Intellis and Abbott's BurstDRT continuously analyse pain signals and adjust stimulation automatically for personalised pain relief.

article thumbnail

Allurion: first HealthTech IPO of 2023 via SPAC with Compute Health

Lloyd Price

The company is led by former Medtronic CEO Omar Ishrak. Additionally, the company has been criticized for its high price tag. The company's gastric balloon is a non-surgical, minimally invasive procedure that is safe and effective for many people. The deal valued Allurion at $500 million.